Archives

by in
Entry Author Date Location
Alnylam Inks $93M Japanese Deal 06/19/08 Boston
$400M Contract for Foster-Miller, 65K Order for OLPC, $1B In, $5M Out for Alnylam, & More Deals News 06/03/08 Boston
Alnylam Inks $1 Billion Deal with Takeda 05/27/08 Boston
BSX Meets With Much Approval, Biogen and Icahn Set the (Showdown) Date, Fate’s Fate Revealed, Win Free Stuff, & More Life Sciences News 05/14/08 Boston
Novartis Increases Stake in Alnylam 05/08/08 Boston
Three Luminaries, Two Third Revolutions, and One Nice Suit: An Xconomy Forum on the Future of Life Sciences in New England 05/02/08 Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals 05/01/08 Boston
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News 04/23/08 Boston
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million 04/17/08 Boston
In Latest Local Venture Philanthropy Deal, Cystic Fibrosis Foundation Pledges up to $37.7 More to Epix 04/07/08 Boston
Mello RNAi Firm RXi Pharmaceuticals Has Wild Ride on First Day of Trading 03/12/08 Boston
Thermo Fisher Simplifies RNAi Delivery 03/10/08 Boston
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News 03/05/08 Boston
Alnylam Touts Early Evidence of RNAi Drug Efficacy 02/29/08 Boston
Alnylam’s John Maraganore Anticipates More RNAi Deals and Startups in “Unparalleled” Environment for Biotech 01/07/08 Boston
Of Red Wine, Robotics, and What Folks Would Do As Governor—Xconomy’s Forum Sparks Debate on the Future of Innovation in New England 12/06/07 Boston
Dicerna Officially Founded 11/14/07 Boston
Will it Rain RNAi Companies? Dicerna Co-Founder John Rossi Says New IP Opens Avenues 11/06/07 Boston
RNAi Firms Find a New Rival (and Partner) in an Old Technology 10/04/07 Boston
Alnylam and Merck Go Their Separate Ways, TransMedics Files to Go Public, ZipCar Reservation System Ready to Go Anywhere, and More 09/24/07 Boston
Mass Biotech Council’s Image Troubles, Boston Scientific’s Mixed Bag, Another Big IPO in the Offing, and More 09/10/07 Boston
Follow-Up: Alnylam’s Biodefense Contract the Program’s Largest 08/10/07 Boston
More Government Dollars for Alnylam Biodefense Initiative 08/09/07 Boston
Page 2 of 2 « previous page